The proof of efficacy of thrombolysis for acute myocardial infarction (AMI) depends on 9 randomized placebo-controlled trials totaling 58,511 patients. The meta-analysis of these trials showed an ...

PE or PEERLESS, the choice of therapy was shifting, influenced by patient factors and institutional protocols.

Acute Myocardial Infarction (MI) managed with thrombolysis in a Polycythemia Vera (PV) patient shows that early diagnostic ...

In patients presenting at thrombectomy-capable stroke centers, the benefit associated with thrombolysis plus thrombectomy vs thrombectomy alone was time dependent and statistically significant only if ...

That was the question up for debate during the WorldLink Forum at TCT 2023, with Rod Stables, MD (Liverpool Heart and Chest Hospital, England), arguing that primary PCI should remain the gold standard ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

Background: The role of immediate transfer for percutaneous coronary intervention (PCI) after thrombolysis for ST-segment elevation myocardial infarction remains controversial. We performed a ...

Controversy exists over whether chronic antiplatelet therapy in patients with acute ischemic stroke is a contraindication to treatment with tissue plasminogen activator (tPA). Antiplatelets impair ...

A modified reperfusion protocol for intermediate-risk pulmonary embolism (PE) seemed to work without causing excessive bleeding in the small randomized CANARY trial. Use of conventional ...

Please provide your email address to receive an email when new articles are posted on . The LLM delivered 94.9% sensitivity and 99.1% specificity. The researchers noted the presence of false positives ...